Top

Published in:

01-08-2006 | Minisymposium

Juvenile idiopathic arthritis: the paediatric perspective

Authors: Alison Jordan, Janet E. McDonagh

Published in: Pediatric Radiology | Issue 8/2006

Abstract

Paediatric rheumatology is a relatively new specialty that has developed rapidly over the last 30 years. There have been major advances, which have included improvements in the classification and management of juvenile idiopathic arthritis (JIA). The former has led to enhanced international collaboration with disease registries, multicentre research and the development of new therapeutic agents. This has resulted in improved disease control and remission induction in many. There is, however, still significant morbidity associated with JIA during childhood, adolescence and adulthood, and challenges for the future include early identification of those with a poorer prognosis, appropriate administration of safe therapies and optimizing outcomes as young people move through adolescence into adulthood.

Murray K, Thompson SD, Glass DN (1997) Pathogenesis of juvenile chronic arthritis: genetic and environmental factors. Arch Dis Child 77:530–534PubMed

Symmons DP, Jones M, Osborne J, et al (1996) Pediatric rheumatology in the United Kingdom: data from the British Paediatric Rheumatology Group National Diagnostic Register. J Rheumatol 23:1975–1980PubMed

Petty RE (2002) Frequency of uncommon diseases: is juvenile idiopathic arthritis under recognized? J Rheumatol 29:1356–1357PubMed

Glass DN, Gianni EH (1999) Juvenile rheumatoid arthritis as a complex genetic trait. Arthritis Rheum 42:2261–2268PubMedCrossRef

Thomson W, Donn R (2002) Juvenile idiopathic arthritis genetics – what’s new? What’s next? Arthritis Res 4:302–306PubMedCrossRef

Prahalad S (2004) Genetics of juvenile idiopathic arthritis: an update. Curr Opin Rheumatol 16:588–594PubMedCrossRef

Petty RE, Southwood TR, Manners P, et al (2004) International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31:390–392PubMed

Edelsten C (2002) An evaluation of baseline risk factors predicting severity in juvenile idiopathic arthritis associated uveitis and other chronic anterior uveitis in early childhood. Br J Ophthalmol 86:1–2CrossRef

Guillaume S, Prieur AM, Coste J, et al (2000) Long-term outcome and prognosis in oligoarticular-onset juvenile idiopathic arthritis. Arthritis Rheum 43:1858–1865PubMedCrossRef

10.

Burgos-Vargas R, Clark P (1989) Axial involvement in the seronegative enthesopathy and arthropathy syndrome and its progression to ankylosing spondylitis. J Rheumatol 16:192–197PubMed

11.

Myers A, McDonagh JE, Gupta K, et al (2004) More ‘cries from the joints’: assessment of the musculoskeletal system is poorly documented in routine paediatric clerking. Rheumatology (Oxford) 43:1045–1049CrossRef

12.

Miller ML (2002) Use of imaging in the differential diagnosis of rheumatic diseases in children. Rheum Dis Clin North Am 28:483–492PubMedCrossRef

13.

Johnson K (2006) Minisymposium – juvenile idiopathic arthritis. Imaging. Pediatr Radiol DOI:10.1007/s00247-006-0199-x

14.

Hackett J, Johnson B, Parkin A, et al (1996) Physiotherapy and occupational therapy for juvenile chronic arthritis: custom and practice in five centres in the UK, USA and Canada. Br J Rheumatol 35:695–699CrossRef

15.

Giannini EH, Brewer EJ, Kuzmina N, et al (1992) Methotrexate in resistant juvenile rheumatoid arthritis. Results of the USA-USSR double-blind, placebo-controlled trial. The Paediatric Rheumatology Collaborative Study Group. N Engl J Med 326:1043–1049PubMedCrossRef

16.

Lovell DJ, Giannini EH, Reiff A, et al (2000) Etanercept in children with polyarticular juvenile rheumatoid arthritis. Paediatric Rheumatology Collaborative Study Group. N Engl J Med 342:763–769PubMedCrossRef

17.

Padeh S, Passwell JH (1998) Intraarticular corticosteroid injection in the management of children with chronic arthritis. Arthritis Rheum 41:1210–1214PubMedCrossRef

18.

Cleary AG, Murphy HD, Davidson JE (2003) Intraarticular corticosteroid injections in juvenile idiopathic arthritis. Arch Dis Child 88:192–196PubMedCrossRef

19.

Eberhard BA, Sison MC, Gottlieb BS, et al (2004) Comparison of the intraarticular effectiveness of triamcinolone hexacetonide and triamcinolone acetonide in treatment of juvenile rheumatoid arthritis. J Rheumatol 31:2507–2512PubMed

20.

Chakravarty K, Pharoah PD, Scott DG (1994) A randomised controlled trial of post-injection rest following steroid therapy for knee synovitis. Br J Rheumatol 33:464–468PubMedCrossRef

21.

Job-Deslandre C, Menkes CJ (1990) Complications of intraarticular injections of triamcinolone hexacetonide in chronic arthritis in children. Clin Exp Rheumatol 8:413–416PubMed

22.

Huppertz H-I, Tschammler A, Horwitz AE, et al (1995) Intraarticular corticosteroids for chronic arthritis in children: efficacy and effects on cartilage and growth. J Pediatr 127:317–321PubMedCrossRef

23.

Wallace CA (1999) On beyond methotrexate treatment of severe juvenile rheumatoid arthritis. Clin Exp Rheumatol 17:499–504PubMed

24.

Adebajo AO, Hall MA (1998) The use of intravenous pulsed methylprednisolone in the treatment of systemic-onset juvenile chronic arthritis. Br J Rheumatol 37:1240–1242PubMedCrossRef

25.

Woo P, Southwood TR, Prieur AM, et al (2000) Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis. Arthritis Rheum 43:1849–1857PubMedCrossRef

26.

Ramanan AV, Whitworth P, Baildam EM (2003) Use of methotrexate in juvenile idiopathic arthritis. Arch Dis Child 88:197–200PubMedCrossRef

27.

Ruperto N, Murray K, Gerloni V, et al (2004) Pediatric Rheumatology International Trials Organization. A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate. Arthritis Rheum 50:2191–2201PubMedCrossRef

28.

van Ede AE, Laan RF, Rood MJ, et al (2001) Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicentre, randomized, double-blind, placebo-controlled study. Arthritis Rheum 44:1515–1524PubMedCrossRef

29.

Cleary AG, McDowell H, Sills JA (2002) Polyarticular juvenile idiopathic arthritis treated with methotrexate complicated by the development of non-Hodgkin's lymphoma. Arch Dis Child 86:47–49PubMedCrossRef

30.

van Rossum MA, Fiselier TJ, Franssen JA, et al (1998) Sulfasalazine in the treatment of juvenile chronic arthritis. Arthritis Rheum 41:808–816PubMedCrossRef

31.

Mouy R, Stephan JL, Pillet P, et al (1996) Efficacy of cyclosporine A in the treatment of macrophage activation syndrome in juvenile arthritis: report of five cases. J Pediatr 129:750–754PubMedCrossRef

32.

Emery HM (1993) Treatment of juvenile rheumatoid arthritis. Curr Opin Rheumatol 5:629–633PubMedCrossRef

33.

Silverman ED, Cawkwell GD, Lovell DJ, et al (1994) Intravenous immunoglobulin in the treatment of systemic juvenile rheumatoid arthritis: a randomized placebo controlled trial. Pediatric Rheumatology Collaborative Study Group. J Rheumatol 21:2353–2358PubMed

34.

Uziel Y, Laer RM, Schneider R, et al (1996) Intravenous immunoglobulin therapy in systemic onset juvenile rheumatoid arthritis: a follow-up study. J Rheumatol 23:910–918PubMed

35.

Wilkinson N, Jackson G, Gardner-Medwin J (2003) Biologic therapies for juvenile arthritis. Arch Dis Child 88:201–205CrossRef

36.

Keystone EC, Schiff MH, Kremer JM, et al (2004) Once-weekly administration of 50 mg etanercept in patients with active rheumatoid arthritis: results of a multicentre, randomized, double-blind, placebo-controlled trial. Arthritis Rheum 50:353–363PubMedCrossRef

37.

van der Heijde D, Klareskog L, Singh A, et al (2006) Patient reported outcomes in a trial of combination therapy with etanercept and methotrexate for rheumatoid arthritis: the TEMPO trial. Ann Rheum Dis 65:328–334PubMedCrossRef

38.

Lovell DJ, Giannini EH, Reiff A, et al; Pediatric Rheumatology Collaborative Study Group (2003) Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: interim results from an ongoing multicenter, open-label, extended-treatment trial. Arthritis Rheum 48:218–226PubMedCrossRef

39.

Gerloni V, Pontikaki I, Gattinara M, et al (2005) Efficacy of repeated intravenous infusions of an anti-tumor necrosis factor alpha monoclonal antibody, infliximab, in persistently active, refractory juvenile idiopathic arthritis: results of an open-label prospective study. Arthritis Rheum 52:548–553PubMedCrossRef

40.

Dekker L, Armhurst W, Rademaker CM, et al (2004) Safety of anti-TNF alpha therapy in children with juvenile idiopathic arthritis. Clin Exp Rheumatol 22:252–258PubMed

41.

Billiau AD, Wouters C (2000) Improved articular and systemic disease in a boy treated with anti-TNFα monoclonal antibody (Remicade) for refractory JIA. Ann Rheum Dis 59 [Suppl 1]:47

42.

British Paediatric Rheumatology Group (2000) Guidelines for the prescribing of biologic agents for children and young adults with juvenile idiopathic arthritis. British Paediatric Rheumatology Group, April 2000 (http://www.rheumatology.org.uk)

43.

NICE (2002) Guidance on the use of etanercept for the treatment of juvenile idiopathic arthritis. Technology Appraisal Guidance No. 35. National Institute for Clinical Excellence, March 2002 (http://www.nice.org.uk)

44.

Wedderburn LR, Abinun M, Palmer P, et al (2003) Autologous haematopoietic stem cell transplantation in juvenile idiopathic arthritis. Arch Dis Child 88:201–205PubMedCrossRef

45.

Shaw KL, Southwood TR, McDonagh JE; British Society of Paediatric and Adolescent Rheumatology (2005) Growing up and moving on in rheumatology: a multicentre cohort of adolescents with juvenile idiopathic arthritis. Rheumatology (Oxford) 44:806–812CrossRef

46.

Packham JC, Hall MA, Pimm TJ (2002) Long-term follow up of 246 adults with juvenile idiopathic arthritis: predictive factors for mood and pain. Rheumatology 41:1444–1449PubMedCrossRef

47.

Sherry DD, Bohnsack J, Salmonson K, et al (1990) Painless juvenile rheumatoid arthritis. J Pediatr Psychol 12:241–255

48.

Ilowite NT, Walco GA, Pochaczevsky R (1992) Assessment of pain in patients with juvenile rheumatoid arthritis: relation between pain intensity and degree of joint inflammation. Ann Rheum Dis 51:343–346PubMed

49.

Simon D, Touati G, Prieur AM, et al (1999) Growth hormone treatment of short stature and metabolic dysfunction in juvenile chronic arthritis. Acta Paediatr Suppl 88:100–105PubMedCrossRef

50.

Simon D, Lucidarme N, Prieur AM, et al (2003) Effects on growth and body composition of growth hormone treatment in children with juvenile idiopathic arthritis requiring steroid therapy. J Rheumatol 30:2492–2499PubMed

51.

Bechtold S, Ripperger P, Bonfig W, et al (2005) Growth hormone changes bone geometry and body composition in patients with juvenile idiopathic arthritis requiring glucocorticoid treatment: a controlled study using peripheral quantitative computed tomography. J Clin Endocrinol Metab 90:3168–3173CrossRef

52.

Henderson CJ, Specker BL, Sierra RI, et al (2000) Total body bone mineral content in non-corticosteroid treated postpubertal females with juvenile rheumatoid arthritis. Arthritis Rheum 43:531–540PubMedCrossRef

53.

Schonau E (1998) Problems of bone analysis in childhood and adolescence. Pediatr Nephrol 12:420–429PubMedCrossRef

54.

Shaw NJ, Bishop NJ (2005) Bisphosphonate treatment of bone disease. Arch Dis Child 90:494–499PubMedCrossRef

55.

Warady B, Lindsley C, Robinson R, et al (1994) Effects of nutritional supplementation on bone mineral status of children with rheumatic disease receiving corticosteroid therapy. J Rheumatol 21:530–535PubMed

56.

Petty RE, Smith JR, Rosenbaum JT (2003) Arthritis and uveitis in children. A pediatric rheumatology perspective. Am J Ophthalmol 135:879–884PubMedCrossRef

57.

Malik AR, Pavesio C (2005) The use of low dose methotrexate in children with chronic anterior and intermediate uveitis. Br J Ophthalmol 89:806–808PubMedCrossRef

58.

Foeldvari I, Wierk A (2005) Methotrexate is an effective treatment for chronic uveitis associated with juvenile idiopathic arthritis. J Rheumatol 32:362–365PubMed

59.

Packham JC, Hall MA (2002) Long-term follow-up of 246 adults with juvenile idiopathic arthritis: functional outcome. Rheumatology (Oxford) 41:1428–1435CrossRef

60.

McDonagh JE, Southwood TR, Shaw KL (2006) Growing up and moving on in rheumatology: development and preliminary evaluation of a transitional care programme for a multicentre cohort of adolescents with juvenile idiopathic arthritis. J Child Health Care 10:22–42PubMedCrossRef

61.

Shaw KL, Southwood TR, McDonagh JE, et al (2005) Growing up and moving on in rheumatology: transitional care and quality of life in a multicentre cohort of adolescents with juvenile idiopathic arthritis. Rheumatology (Oxford) 44 [Suppl 1]:199

62.

Shaw KL, Southwood TR, McDonagh JE, et al (2004) Developing a programme of transitional care for adolescents with juvenile idiopathic arthritis: results of a postal survey. Rheumatology (Oxford) 43:211–219CrossRef

63.

Ullrich G, Mattussek S, Dressler F, et al (2002) How do adolescents with juvenile chronic arthritis consider their disease related knowledge, their unmet service needs and the attractiveness of various services? Eur J Med Res 7:8–18PubMed

64.

Barlow JH, Shaw KL, Harrison K (1999) Consulting the ‘experts’: children’s and parents’ perceptions of psycho-educational interventions in the context of juvenile chronic arthritis. Health Educ Res 14:597–610PubMedCrossRef

65.

Klein JD, Allan MJ, Elster AB, et al (2001) Improving adolescent preventive care in community health centers. Pediatrics 107:318–327PubMedCrossRef

66.

Gage H, Hampson S, Skinner TC, et al (2004) Educational and psychosocial programmes for adolescents with diabetes: approaches, outcomes and cost effectiveness. Patient Educ Couns 53:333–346PubMedCrossRef

67.

Kyngas H (2003) Patient education: perspective of adolescents with a chronic disease. J Clin Nurs 12:744–751PubMedCrossRef

68.

Guevara JP, Wolf FM, Grum CM, et al (2003) Effects of educational interventions for self management of asthma in children and adolescents: systematic review and meta-analysis. BMJ 326:1308–1309PubMedCrossRef

69.

McDonagh JE, Southwood TR, Shaw KL, et al (2005) Growing up and moving on in rheumatology: disease knowledge in a multicentre cohort of adolescents with juvenile idiopathic arthritis. Arch Dis Child 90 [Suppl II]:A51

70.

Klepper S, Darbee J, Effgenr SK, et al (1992) Physical fitness levels in children with polyarticular juvenile rheumatoid arthritis. Arthritis Care Res 5:93–100PubMedCrossRef

71.

Petersen LS, Mason T, Nelson AM, et al (1997) Psychosocial outcomes and health studies in adults who have had juvenile arthritis: a controlled population based study. Arthritis Rheum 40:2235–2240CrossRef

72.

Stewart AL, Hays RD, Wells KB, et al (1994) Long-term functioning and well-being outcomes associated with physical activity and exercise in patients with chronic conditions in the Medical outcomes study. J Clin Epidemiol 47:719–730PubMedCrossRef

73.

Kotaniemi A, Savolainen A, Kroger H, et al (1999) Weight-bearing physical activity, calcium intake, systemic glucocorticoids, chronic inflammation and body constitution as determinants of lumbar and femoral bone mineral in juvenile chronic arthritis. Scand J Rheumatol 28:19–26PubMedCrossRef

74.

Nash AA, Britto MT, Lovell DJ, et al (1998) Substance use among adolescents with juvenile rheumatoid arthritis. Arthritis Care Res 11:391–396PubMedCrossRef

75.

Suris JC, Resnick MD, Cassuto N, et al (1996) Sexual behaviour of adolescents with chronic disease and disability. J Adolesc Health 19:124–131PubMedCrossRef

76.

Blumenfeld Z, Lorber M, Yoffe N, et al (1994) Systemic lupus erythematosus: predisposition for uterine cervical dysplasia. Lupus 3:59–61PubMedCrossRef

77.

Packham JC, Hall MA (2002) Long-term follow-up of 246 adults with juvenile idiopathic arthritis: social function, relationships and sexual activity. Rheumatology (Oxford) 41:1440–1443CrossRef

78.

Ostensen M, Almberg K, Koksvik HS (2000) Sex, reproduction and gynecological disease in young adults with a history of juvenile chronic arthritis. J Rheumatol 27:1783–1787PubMed

79.

Britto MT, Rosenthal SL, Taylor J, et al (2000) Improving rheumatologists’ screening for alcohol use and sexual activity. Arch Pediatr Adolesc Med 154:478–483PubMed

80.

Giannini EH, Ruperto N, Ravelli A, et al (1997) Preliminary definition of improvement in juvenile in juvenile arthritis. Arthritis Rheum 40:1202–1209PubMed

81.

Gare BA, Fasth A (1995) The natural history of juvenile chronic arthritis: a population based cohort study. II. Outcome. J Rheumatol 22:308–319PubMed

82.

David J, Cooper C, Hickey L, et al (1994) The functional and psychological outcomes of juvenile chronic arthritis in young adulthood. Br J Rheumatol 33:876–881PubMedCrossRef

83.

Ruperto N, Levinson JE, Ravelli A, et al (1997) Long-term health outcomes and quality of life in American and Italian inception cohorts of patients with juvenile rheumatoid arthritis. I. Outcome status. J Rheumatol 24:945–951PubMed

84.

Foster HE, Marshall N, Myers A, et al (2003) Outcome in adults with juvenile idiopathic arthritis: a quality of life study. Arthritis Rheum 48:767–775PubMedCrossRef

85.

Oen K, Malleson P, Cabral DA, et al (2002) Disease course and outcome of juvenile rheumatoid arthritis in a multicentre cohort. J Rheumatol 29:1989–1999PubMed

86.

Packham JC, Hall MA (2002) Long-term follow-up of 246 adults with juvenile idiopathic arthritis: education and employment. Rheumatology (Oxford) 41:1436–1439CrossRef

Title: Juvenile idiopathic arthritis: the paediatric perspective
Authors: Alison Jordan
Janet E. McDonagh
Publication date: 01-08-2006
Publisher: Springer-Verlag
Published in: Pediatric Radiology / Issue 8/2006
Print ISSN: 0301-0449
Electronic ISSN: 1432-1998
DOI: https://doi.org/10.1007/s00247-006-0165-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Juvenile idiopathic arthritis: the paediatric perspective

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 8/2006

Pantothenate kinase 2 mutation with classic pantothenate-kinase-associated neurodegeneration without ‘eye-of-the-tiger’ sign on MRI in a pair of siblings

The Latin American Society of Pediatric Radiology (SLARP)

Imaging of juvenile idiopathic arthritis

Radiological–pathological correlation in lipoblastoma and lipoblastomatosis

Liver, meconium, haemorrhage: the value of T1-weighted images in fetal MRI

Pediatric Radiology Continuing Medical Education Activity